Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066196
Status:
COMPLETED
Last Update Posted:
2008-01-15
First Post:
2003-08-05
Brief Title:
Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
MI-CP095
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Luz Hammershaimb MD VP Clinical Dev
Old Organization:
MedImmune Inc